Literature DB >> 34306454

Analysis of inflammatory factor levels in serum and risk factors in patients with chronic renal failure undergoing maintenance hemodialysis.

Min Zhou1, Yuan Du1, Yanping Wu1, Ping Zhang1, Peng Liu1, Jiarui Li1.   

Abstract

PURPOSE: To investigate the therapeutic effect of maintenance hemodialysis in patients with chronic renal failure and summarize the analysis of inflammatory factors in serum, and the risk factors in patients with chronic renal failure undergoing maintenance hemodialysis.
METHODS: A total of 50 patients with chronic renal failure undergoing maintenance hemodialysis who were admitted to our hospital from January 2017 to January 2019 were selected as the research subjects to analyze the therapeutic effects and complications of maintenance hemodialysis of these patients, compare the changes of inflammatory factor levels in serum such as interleukin-2 (IL-2), interleukin-6 (IL-6), and high-sensitivity C-reactive protein (hs-CRP) and renal function indicators such as creatinine, urea nitrogen, and urinary albumin clearance, and analyze the risk factors of maintenance hemodialysis in patients with chronic renal failure by multivariate logistic factor analysis.
RESULTS: The effective rate of maintenance hemodialysis in patients with chronic renal failure was 64% (32 cases). After dialysis, urea nitrogen, urinary albumin and creatinine clearance were significantly decreased (P < 0.05). As for the complications, 10 patients died, and 8 patients had infection. The levels of inflammatory factors in serum, such as IL-2, hs CRP were significantly decreased after maintenance hemodialysis (P < 0.05), and the difference was statistically significant. The results of multivariate logistic factor analysis showed that high capacity load and anemia were independent risk factors for death in patients with chronic renal failure undergoing maintenance hemodialysis. Simultaneously, diabetes mellitus, central venous catheterization, and hypoalbuminemia were independent risk factors for infection in patients with chronic renal failure undergoing maintenance hemodialysis.
CONCLUSION: The level of inflammatory factors in the serum of patients with chronic renal failure after maintenance hemodialysis was significantly reduced. The risk factors of death and infection include hypertension, anemia, diabetes, etc. In contrast, the independent risk factors of death were anemia and high capacity load, and the independent risk factors of infection were diabetes, hypoalbuminemia, and central venous catheterization. AJTR
Copyright © 2021.

Entities:  

Keywords:  Chronic renal failure; inflammatory factors in serum; maintenance hemodialysis; risk factors

Year:  2021        PMID: 34306454      PMCID: PMC8290784     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  18 in total

1.  Chronic Inhibition of CYP3A is Temporarily Reduced by Each Hemodialysis Session in Patients With End-Stage Renal Disease.

Authors:  Erlend Johannessen Egeland; Bartlomiej J Witczak; Hasse Khiabani Zaré; Hege Christensen; Anders Åsberg; Ida Robertsen
Journal:  Clin Pharmacol Ther       Date:  2020-06-01       Impact factor: 6.875

2.  Nitric oxide and TNF-α are correlates of diabetic retinopathy independent of hs-CRP and HbA1c.

Authors:  Pegah Khaloo; Reihane Qahremani; Soghra Rabizadeh; Mohammad Omidi; Armin Rajab; Firouzeh Heidari; Ghasem Farahmand; Masoume Bitaraf; Hossein Mirmiranpour; Alireza Esteghamati; Manouchehr Nakhjavani
Journal:  Endocrine       Date:  2020-06-03       Impact factor: 3.633

3.  No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial.

Authors:  Brendan Smyth; Li Zuo; Nicholas A Gray; Christopher T Chan; Janak R de Zoysa; Daqing Hong; Kris Rogers; Jia Wang; Alan Cass; Martin Gallagher; Vlado Perkovic; Meg Jardine
Journal:  Nephrology (Carlton)       Date:  2020-07-02       Impact factor: 2.506

4.  Meta-Analysis Treatment Hyperphosphatemia Chronic Renal Failure Based on Nano Lanthanum Hydroxide.

Authors:  Min Jiang; Hengheng Zheng; Chengliang Xu; Ye Wang; Tingxin Wan
Journal:  J Nanosci Nanotechnol       Date:  2020-10-01

5.  Time to Conversion to an Everolimus-Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry.

Authors:  Faouzi Saliba; Sébastien Dharancy; Ephrem Salamé; Filoména Conti; Daniel Eyraud; Sylvie Radenne; Térésa Antonini; Olivier Guillaud; Jean Guguenheim; Martine Neau-Cransac; Eléonora Demartin; Guillaume Lasailly; Christophe Duvoux; Rodolphe Sobesky; Audrey Coilly; Sylvie Tresson; Valérie Cailliez; Olivier Boillot; Georges Philippe Pageaux; Didier Samuel; Yvon Calmus; Jérôme Dumortier
Journal:  Liver Transpl       Date:  2020-10-12       Impact factor: 5.799

6.  Association between pill burden and interdialytic weight gain in patients with hemodialysis: A multi-center cross-sectional study.

Authors:  Masaru Murasawa; Atsuko Uehara; Tomo Suzuki; Sayaka Shimizu; Shigeki Kojima; Daisuke Uchida; Takeshi Okamoto; Toru Naganuma; Sho Sasaki; Naohiko Imai; Akihiro Chikaraishi; Shigeaki Matsukawa; Hiroo Kawarazaki; Tsutomu Sakurada; Yugo Shibagaki
Journal:  Ther Apher Dial       Date:  2020-11-20       Impact factor: 1.762

7.  Initiation of peritoneal dialysis in a patient with chronic renal failure associated with tetralogy of Fallot: a case report.

Authors:  Tetsuya Abe; Togo Aoyama; Keiko Sano; Ryoma Miyasaka; Takuya Yamazaki; Yukari Honma; Hiroshi Tominaga; Maoko Ida; Aya Arao; Mayuko Sakakibara; Keiko Hashimoto; Haruka Takahashi; Takeshi Sakai; Shokichi Naito; Toshimi Koitabashi; Takashi Sano; Yasuo Takeuchi
Journal:  BMC Nephrol       Date:  2020-07-15       Impact factor: 2.388

8.  Efficacy of favipiravir for an end stage renal disease patient on maintenance hemodialysis infected with novel coronavirus disease 2019.

Authors:  Eri Koshi; Shoji Saito; Masaki Okazaki; Yuki Toyama; Takuji Ishimoto; Tomoki Kosugi; Hiroaki Hiraiwa; Naruhiro Jingushi; Takanori Yamamoto; Masayuki Ozaki; Yukari Goto; Atsushi Numaguchi; Yasuhiro Miyagawa; Io Kato; Nobuyuki Tetsuka; Tetsuya Yagi; Shoichi Maruyama
Journal:  CEN Case Rep       Date:  2020-09-17

9.  Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis.

Authors:  Yin Zheng; Zihui Tang; Li You; Yuanhao Wu; Junfeng Liu; Jun Xue
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

10.  A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.

Authors:  Antoney J Ferrey; Grace Choi; Ramy M Hanna; Yongen Chang; Ekamol Tantisattamo; Kaushik Ivaturi; Elisa Park; Lawrence Nguyen; Brian Wang; Sam Tonthat; Connie M Rhee; Uttam Reddy; Wei Ling Lau; Susan S Huang; Shruti Gohil; Alpesh N Amin; Lanny Hsieh; Timmy T Cheng; Richard A Lee; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2020-03-28       Impact factor: 3.754

View more
  1 in total

Review 1.  Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.

Authors:  Yinghui Wang; Lu Gao
Journal:  Front Pharmacol       Date:  2022-02-10       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.